These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 4403158

  • 1. [Pharmacologic justification for the use of adrenergic beta receptor blockaders in angina].
    Boissier JR, Giudicelli JF.
    Therapie; 1970; 25(2):363-92. PubMed ID: 4403158
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of beta-blockaders on coronary output: study in humans using xenon- 133 ].
    Lichtlen P, Albert H, Moccetti T.
    Therapie; 1970; 25(2):403-8. PubMed ID: 4403160
    [No Abstract] [Full Text] [Related]

  • 3. [Adrenergic beta receptor blockaders in the treatment of angina pectoris].
    Londres G.
    Hospital (Rio J); 1969 Oct; 76(4):1179-82. PubMed ID: 4391342
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K.
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract] [Full Text] [Related]

  • 5. [Qualification of patients with angina pectoris for beta-adrenolytic drug treatment].
    Lukasik S, Wrabec K, Nowosad H.
    Kardiol Pol; 1974 Jul; 17(6):563-8. PubMed ID: 4155457
    [No Abstract] [Full Text] [Related]

  • 6. [Coronary drugs].
    de Lostalot J, Quilichini R.
    Bord Med; 1972 Feb; 5(4):343-54. PubMed ID: 4402981
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological approaches to the therapy of angina.
    Parratt JR.
    Adv Drug Res; 1974 Feb; 9():103-34. PubMed ID: 4156950
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D, Frisch P, Klepzig H.
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV.
    J Clin Pharmacol New Drugs; 1971 Apr; 11(4):249-60. PubMed ID: 4397374
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive drug management of angina pectoris.
    Pepine CJ, Feldman RL, Conti CR.
    Cardiovasc Clin; 1984 Apr; 14(3):139-51. PubMed ID: 6144388
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of coronary insufficiency with beta-receptor antagonists (author's transl)].
    Hitzenberger G.
    Arzneimittelforschung; 1977 Apr; 27(3a):700-2. PubMed ID: 17414
    [Abstract] [Full Text] [Related]

  • 18. [Adrenergic and anti-adrenergic mechanisms of substances with anti-anginal effects].
    Palm D.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 Apr; 263(1):159-67. PubMed ID: 4389904
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic actions of nitrite-beta-adrenergic blocking agents in the therapy of angina pectoris. Pharmacologic and therapeutic rationale.
    Klein HO, Berger HJ.
    Cardiology; 1973 Apr; 58(6):313-25. PubMed ID: 4153989
    [No Abstract] [Full Text] [Related]

  • 20. [What is certain in the therapy of coronary insufficiency?].
    Michel D.
    Fortschr Med; 1972 Sep 14; 90(25):889-92. PubMed ID: 4404925
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.